IORT reimbursement unchanged; payment values for alternative, longer courses of radiation therapy reduced

NASHUA, N.H., Sept. 20, 2020 (GLOBE NEWSWIRE) — iCAD,
Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, is providing additional comments following the Centers for Medicare &
Medicaid Services’ (CMS) publication of a new